U.K. COVID-19 vaccine to be delivered by skin patch approved for human trials

CTV News: A U.K. company that developed a new COVID-19 vaccine intended to be delivered via a small skin patch with microneedles has been granted approval for human trials. Oxfordshire-based company “Emergex” developed a vaccine for SARS-CoV-2 that is designed to prime T-cells (white blood cells that are part of the immune system) in the body to rapidly remove virus-infected cells.

Hopefully this new vaccine is not abortion tainted, safe, and actually works to provide broad spectrum protection and herd immunity.

Recent Posts

See All